(Sterol)ized Immunity: Could PI3K/AKT3 Be the Answer?

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Type I interferons (IFNs) are crucial for innate immunity.
• IFNs can modulate cellular metabolic pathways, including cholesterol biosynthesis.
• The precise mechanisms by which IFNs enhance immune responses via metabolic reprogramming are not fully understood.

Purpose of the Study:

• To investigate the role of cholesterol biosynthesis in type I IFN-mediated innate immune responses.
• To elucidate the molecular mechanisms linking type I IFN signaling to metabolic changes.
• To understand how these changes contribute to controlling viral infections.

Main Methods:

• Analysis of gene expression and protein levels in response to type I IFNs.
• Metabolic profiling to assess cholesterol biosynthesis intermediates.
• Cellular assays to evaluate viral replication and immune cell activation.
• Pharmacological inhibition and genetic manipulation of key pathway components.

Main Results:

• Type I IFN signaling induces significant reprogramming of the cholesterol biosynthetic pathway.
• Accumulation of 7-dehydrocholesterol (7-DHC) was observed upon type I IFN stimulation.
• A positive feedback loop was identified where 7-DHC accumulation amplifies type I IFN signaling via AKT3 activation.
• This loop enhances the innate immune response against viral infections.

Conclusions:

• Type I IFNs utilize 7-DHC accumulation to create a positive feedback loop that amplifies innate immunity.
• The activation of AKT3 by 7-DHC is a key mechanism in this feedback loop.
• This metabolic reprogramming strategy is essential for effective viral control.